Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1993 Aug;68(2):433–435. doi: 10.1038/bjc.1993.355

Prognostic value of the S-phase fraction of breast cancer.

Y Remvikos
PMCID: PMC1968557  PMID: 8240522

Full text

PDF
434

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dutrillaux B., Gerbault-Seureau M., Remvikos Y., Zafrani B., Prieur M. Breast cancer genetic evolution: I. Data from cytogenetics and DNA content. Breast Cancer Res Treat. 1991 Nov;19(3):245–255. doi: 10.1007/BF01961161. [DOI] [PubMed] [Google Scholar]
  3. Héry M., Gioanni J., Lalanne C. M., Namer M., Courdi A. The DNA labelling index: a prognostic factor in node-negative breast cancer. Breast Cancer Res Treat. 1987;9(3):207–211. doi: 10.1007/BF01806381. [DOI] [PubMed] [Google Scholar]
  4. Joensuu H., Alanen K., Falkmer U. G., Klemi P., Nordling S., Remvikos Y., Toikkanen S. Effect of DNA ploidy classification on prognosis in breast cancer. Int J Cancer. 1992 Nov 11;52(5):701–706. doi: 10.1002/ijc.2910520506. [DOI] [PubMed] [Google Scholar]
  5. Magdelenat H., Gerbault-Seureau M., Laine-Bidron C., Prieur M., Dutrillaux B. Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression. Breast Cancer Res Treat. 1992;22(2):119–127. doi: 10.1007/BF01833341. [DOI] [PubMed] [Google Scholar]
  6. McGuire W. L. Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst. 1991 Feb 6;83(3):154–155. doi: 10.1093/jnci/83.3.154. [DOI] [PubMed] [Google Scholar]
  7. Meyer J. S. Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma. NCI Monogr. 1986;(1):25–28. [PubMed] [Google Scholar]
  8. O'Reilly S. M., Camplejohn R. S., Rubens R. D., Richards M. A. DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer. Eur J Cancer. 1992;28(2-3):681–683. doi: 10.1016/s0959-8049(05)80124-8. [DOI] [PubMed] [Google Scholar]
  9. O'Reilly S. M., Richards M. A. Is DNA flow cytometry a useful investigation in breast cancer? Eur J Cancer. 1992;28(2-3):504–507. doi: 10.1016/s0959-8049(05)80088-7. [DOI] [PubMed] [Google Scholar]
  10. Peters L. J., Brock W. A., Chapman J. D., Wilson G. Predictive assays of tumor radiocurability. Am J Clin Oncol. 1988 Jun;11(3):275–287. doi: 10.1097/00000421-198806000-00005. [DOI] [PubMed] [Google Scholar]
  11. Remvikos Y., Beuzeboc P., Zajdela A., Voillemot N., Magdelénat H., Pouillart P. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst. 1989 Sep 20;81(18):1383–1387. doi: 10.1093/jnci/81.18.1383. [DOI] [PubMed] [Google Scholar]
  12. Remvikos Y., Gerbault-Seureau M., Magdelénat H., Prieur M., Dutrillaux B. Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis. Breast Cancer Res Treat. 1992;23(1-2):43–49. doi: 10.1007/BF01831474. [DOI] [PubMed] [Google Scholar]
  13. Silvestrini R., Daidone M. G., Valagussa P., Di Fronzo G., Mezzanotte G., Bonadonna G. Cell kinetics as a prognostic indicator in node-negative breast cancer. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1165–1171. doi: 10.1016/0277-5379(89)90410-0. [DOI] [PubMed] [Google Scholar]
  14. Spyratos F., Briffod M., Tubiana-Hulin M., Andrieu C., Mayras C., Pallud C., Lasry S., Rouëssé J. Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up. Cancer. 1992 Jan 15;69(2):470–475. doi: 10.1002/1097-0142(19920115)69:2<470::aid-cncr2820690233>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  15. Stanton P. D., Cooke T. G., Oakes S. J., Winstanley J., Holt S., George W. D., Murray G. D. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Br J Cancer. 1992 Nov;66(5):925–929. doi: 10.1038/bjc.1992.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tubiana M., Pejovic M. H., Koscielny S., Chavaudra N., Malaise E. Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int J Cancer. 1989 Jul 15;44(1):17–22. doi: 10.1002/ijc.2910440104. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES